Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Innoviva's Liabilities and Shareholders Equity rose 1603.54% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year increase of 705.53%. This contributed to the annual value of $1.3 billion for FY2024, which is 462.83% up from last year.
  • As of Q3 2025, Innoviva's Liabilities and Shareholders Equity stood at $1.4 billion, which was up 1603.54% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Innoviva's Liabilities and Shareholders Equity registered a high of $1.4 billion during Q3 2025, and its lowest value of $789.2 million during Q2 2021.
  • Over the past 5 years, Innoviva's median Liabilities and Shareholders Equity value was $1.2 billion (recorded in 2024), while the average stood at $1.2 billion.
  • As far as peak fluctuations go, Innoviva's Liabilities and Shareholders Equity surged by 4964.54% in 2022, and later crashed by 1051.49% in 2023.
  • Innoviva's Liabilities and Shareholders Equity (Quarter) stood at $926.4 million in 2021, then skyrocketed by 32.93% to $1.2 billion in 2022, then grew by 0.98% to $1.2 billion in 2023, then grew by 4.63% to $1.3 billion in 2024, then rose by 9.84% to $1.4 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.4 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.